TL;DR High blood cancer mortality persists due to late-stage diagnosis, with over 60% of patients presenting with advanced disease despite treatment breakthroughs [2] Treatment resistance mechanisms affect 30-40% of blood cancer patients, leading to relapse even after initial remission with modern therapies Pi Cancer Care by Dr.Bh arat Patodiya, personalized treatment protocols and real-time monitoring systems address key mortality factors through comprehensive patient evalua